FDA: Vytorin Unlikely to Up Cancer Risk
WWW.WEBMD.COM - The FDA has backed off a 2008 statement describing a possible link between use of the cholesterol-lowering drug Vytorin and cancer, saying any connection is unlikely but shouldn't be ruled out.
First tweeted by WellnessInfo.
From the Front Page
- Comments
- Tweets (32)
Tweets
Sorry there have been no tweets in the last 7 days.
